İlknur ALSAN ÇETİN, Erkan ÖZGEN, Merve SEVINDIK, Rabia ERGELEN, Ayşe DAĞLI DEĞERLİ

Comparison of Contouring Results for Prostate Cancer Treatment Planning Obtained by Two Different Specialists

This study is a comparison of contoured diagnostic images derived from computed tomography (CT) and magnetic resonance imaging (MRI) by both a radiation oncologist (RO) and a radiologist (R) using volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) techniques.METHODSCT and MRI sections of 16 patients were contoured by the RO and the R. Planning target volume (PTV) criteria assessed were conformity index (CI), homogeneity index (HI), volume covered by 98% isodose line (V 98%) and maximum dose (Dmax). In critical organs, 40 Gy organ area volume (V40), 65 Gy organ area volume (V65), and Dmeanstatistical analysis. criteria were evaluated. Paired samples t-test was used for RESULTSPTV and critical organs were compared. MRI PTV and bladder volume drawn by R were lower. Comparison of CT images revealed IMRT plans were superior in terms of Dmax and CI, while V40 and Dmeanvalues for rectum and bladder were lower in MRI-based VMAT plans. In MRI plans, IMRT was superior in terms of PTV, Dmax, CI, V65, and Dmean for critical organs; however, critical organs were well preserved with both planning techniques.CONCLUSIONThere was some difference between contouring of the R and the RO, which was reflected in the treatment plans

PDF

___

1. Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, et al. Comparison of conventionaldose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294(10):1233–9.
2. Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 2007;8(6):475–87.
3. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53(5):1097–105.
4. Khoo VS. MRI--”magic radiotherapy imaging” for treatment planning? Br J Radiol 2000;73(867):229–33.
5. Sannazzari GL, Ragona R, Ruo Redda MG, Giglioli FR, Isolato G, Guarneri A. CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol 2002;75(895):603–7.
6. Sefrova J, Odrazka K, Paluska P, Belobradek Z, Brodak M, Dolezel M, et al. Magnetic resonance imaging in postprostatectomy radiotherapy planning. Int J Radiat Oncol Biol Phys 2012;82(2):911–8. 7. Khoo VS, Joon DL. New developments in MRI for target volume delineation in radiotherapy. Br J Radiol 2006;79:2–15.
8. Smith WL, Lewis C, Bauman G, Rodrigues G, D’Souza D, Ash R, et al. Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys 2007;67(4):1238–47.
9. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999;43(1):57–66.
10.Steenbakkers RJ, Deurloo KE, Nowak PJ, Lebesque JV, van Herk M, Rasch CR. Reduction of dose delivered to the rectum and bulb of the penis using MRI delineation for radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 2003;57(5):1269–79.
11.Milosevic M, Voruganti S, Blend R, Alasti H, Warde P, McLean M, et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. Radiother Oncol 1998;47(3):277–84.
12.Kopp RW, Duff M, Catalfamo F, Shah D, Rajecki M, Ahmad K. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample. Med Dosim 2011;36(4):365–72.
13.Sze HC, Lee MC, Hung WM, Yau TK, Lee AW. RapidArc radiotherapy planning for prostate cancer: single-arc and double-arc techniques vs. intensity-modulated radiotherapy. Med Dosim 2012;37(1):87–91.
14.Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 2008;35(1):310–7.
15.Villeirs GM, Van Vaerenbergh K, Vakaet L, Bral S, Claus F, De Neve WJ, et al. Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 2005;181(7):424–30.
16.Hanvey S, Sadozye AH, McJury M, Glegg M, Foster J. The influence of MRI scan position on image registration accuracy, target delineation and calculated dose in prostatic radiotherapy. Br J Radiol 2012;85(1020):e1256–62.
17.Wolff D, Stieler F, Welzel G, Lorenz F, Abo-Madyan Y, Mai S, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 200;93(2):226–33.
18.Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008;72(4):996–1001.
19.Fontenot JD, King ML, Johnson SA, Wood CG, Price MJ, Lo KK. Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixedbeam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement. Br J Radiol 2012;85(1011):231–6.
20.Chow JC, Jiang R. Comparison of dosimetric variation between prostate IMRT and VMAT due to patient’s weight loss: Patient and phantom study. Rep Pract Oncol Radiother 2013;18(5):272–8.
21.Elith CA, Dempsey SE, Warren-Forward HM. A retrospective planning analysis comparing intensity modulated radiation therapy (IMRT) to volumetric modulated arc therapy (VMAT) using two optimization algorithms for the treatment of early-stage prostate cancer. J Med Radiat Sci 2013;60(3):84–92.

ISSN: 1300-7467
Başlangıç: 2015
Yayıncı: Ali Cangül

Arşiv